Found vs Henry Meds for GLP-1: 2026 Comparison
An independent, side-by-side comparison of Found and Henry Meds for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.

Quick Verdict
Best Price
Henry Meds
Starting at $149/mo vs $159/mo
Most Medications
Found
2 medications vs 2
Best for Beginners
Henry Meds
Async Telehealth, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Found | Henry Meds | Savings |
|---|---|---|---|
| Semaglutide | $159/monthly | $149/monthly | Similar pricing |
| Tirzepatide | $399/monthly | $349/monthly | Save $50/mo with Henry Meds |
Pros and Cons
Found
- Holistic approach — medication + coaching + community
- Board-certified obesity medicine specialists
- Competitive compounded semaglutide pricing
- Personalized weight-loss plans with behavior change focus
- Slower shipping than competitors (5-7 days)
- No lab testing included
- Coaching quality can vary
- Limited to weight-loss medications only
Henry Meds
- Among the lowest compounded GLP-1 pricing available
- Fast onboarding process (prescriptions within 24-48 hours)
- No consultation fee
- Free shipping included
- Async-only — no video consultations
- No lab testing included
- Relatively new company with limited track record
- Only compounded medications (no brand-name options)
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By maria-torres · Last updated April 1, 2026
Found vs Henry Meds for GLP-1: 2026 Comparison
Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.
Found and Henry Meds share an address in telehealth GLP-1 treatment but operate from completely different philosophies. Henry Meds is a lean, cash-pay prescribing platform — compounded semaglutide at $149/month, compounded tirzepatide at $349/month, no extras. Found wraps medication inside a behavioral coaching program, handles insurance navigation for brand-name drugs, and charges a program fee on top of medication cost.
Henry Meds is the cheaper option for patients who want compounded tirzepatide or semaglutide without coaching. Found is the better fit for patients who want structured behavioral support alongside their medication, or who need insurance navigation for brand-name Wegovy or Zepbound.
How do Found and Henry Meds compare on price?
Henry Meds is cheaper for medication-only access. Found charges a program fee in addition to the medication cost — and that program fee is not publicly disclosed on their website, which makes all-in cost comparisons difficult. Patients should verify total cost at enrollment before committing.
Pricing last verified April 2026. We update pricing data monthly.
| Found | Henry Meds | |
|---|---|---|
| Compounded semaglutide | Not offered | $149/mo |
| Compounded tirzepatide | Not offered | $349/mo |
| Orforglipron | $149/mo + program fee | Not available |
| Oral Wegovy (brand) | Insurance or cash + program fee | Not available |
| Brand Zepbound (tirzepatide) | $299/mo + program fee | Not available |
| Medicare Bridge | ~$50/mo copay + program fee | Not available |
| Loyalty discount | None | $129/mo after 6 months |
| Coaching | Included in program fee | Not available |
| Consultation | Video + async | Async only |
| Shipping | 5–7 business days | Free, 3–5 business days |
Found does not publish its program fee separately from medication costs. The all-in monthly cost is higher than Henry Meds across every medication tier, but the comparison is not straightforward — Found's fee funds coaching and video consultations that Henry Meds does not provide.
Henry Meds long-term patients benefit from a loyalty discount: compounded semaglutide drops to $129/month after six continuous months, saving $240/year against the standard rate. Found has no equivalent.
What medications does each provider offer?
This is the most consequential difference between the two platforms. They have almost no overlapping formulary.
Henry Meds offers two products: compounded semaglutide and compounded tirzepatide — both from 503B-registered outsourcing facilities. No brand-name medications. No insurance pathway.
Found no longer offers compounded GLP-1 medications following FDA enforcement actions through 2025–2026. Their current formulary is entirely brand-name: orforglipron (pending FDA approval; PDUFA April 10, 2026), oral Wegovy, injectable Wegovy (via insurance), Wegovy HD, and Zepbound. Found handles prior authorizations for insurance-covered injectable medications.
| Medication | Found | Henry Meds |
|---|---|---|
| Compounded semaglutide | ❌ | ✅ $149/mo |
| Compounded tirzepatide | ❌ | ✅ $349/mo |
| Orforglipron (pending approval) | ✅ $149/mo + fee | ❌ |
| Oral Wegovy (brand) | ✅ + program fee | ❌ |
| Brand Zepbound | ✅ $299/mo + program fee | ❌ |
| Injectable Wegovy (via insurance) | ✅ with PA support | ❌ |
For patients specifically comparing tirzepatide options: Henry Meds offers compounded tirzepatide at $349/month as a flat cash-pay price. Found's Zepbound access is $299/month plus the undisclosed program fee — almost certainly more expensive — and requires going through Found's program model. Between these two providers, Henry Meds is the only source for compounded tirzepatide at a transparent flat price.
Tirzepatide clinical context: tirzepatide is a dual GIP/GLP-1 receptor agonist. The SURMOUNT-1 trial demonstrated 22.5% mean body weight loss at the 15mg dose over 72 weeks (Jastreboff et al., NEJM 2022). A head-to-head trial (SURMOUNT-5) showed 47% more total weight loss with tirzepatide compared to semaglutide. Starting dose is 2.5mg/week, titrated upward in 2.5mg increments every four weeks based on tolerance.
What is Found's coaching model and does Henry Meds have anything equivalent?
Found's program model is the primary reason its all-in cost is higher than Henry Meds. Henry Meds has no behavioral program — it is an async prescription service.
Found structures care around three components:
- Board-certified obesity medicine physicians — Video consultations available, not just async messaging. This distinguishes Found from Henry Meds and Ro, which are async-only.
- Behavioral coaching — Regular check-ins focused on eating patterns, sleep, stress, and physical activity alongside medication. Group forums and educational curriculum built around sustainable habit formation.
- Structured clinical intake — Found's questionnaire covers behavioral and lifestyle factors, not just BMI and health history.
The STEP 1 extension trial showed participants regained approximately 67% of lost weight within one year of discontinuing semaglutide (Wilding et al., Diabetes Obes Metab 2022). Building habits during the medication period is one of the few available interventions to reduce that regain risk. Found's model is designed around this.
That said, coaching quality varies. Not all Found coaches provide the same level of engagement, and the coaching is not equivalent to the intensive behavioral therapy studied in controlled clinical settings.
Henry Meds offers provider messaging for dose adjustments and clinical questions — that is the extent of clinical support. Patients who want coaching will not find it at Henry Meds.
How does insurance work at Found vs Henry Meds?
Found navigates insurance for brand-name injectable medications (Wegovy, Zepbound) and handles prior authorization paperwork. Medicare patients can access GLP-1 coverage through Found's Medicare Bridge Program at approximately $50/month copay plus the program fee.
Henry Meds is cash-pay only. They do not offer insurance navigation and do not carry any medications that would be covered by a standard insurance plan. Patients whose employer plan covers Wegovy or Zepbound receive no benefit from Henry Meds — they should go to Found, Calibrate, or FORM Health instead.
| Insurance factor | Found | Henry Meds |
|---|---|---|
| Accepts insurance | Yes (injectable medications) | No |
| Prior authorization support | ✅ | ❌ |
| Medicare Bridge access | ✅ (~$50/mo copay) | ❌ |
| Cash-pay medications | Yes (orforglipron, Zepbound) | Yes (compounded only) |
How do the platforms work day-to-day?
| Platform feature | Found | Henry Meds |
|---|---|---|
| Consultation model | Video + async | Async only |
| Prescription turnaround | 24–48 hours | 24–48 hours |
| First shipment | 5–7 business days | 3–5 business days |
| Lab testing | No | No |
| Coaching | Yes (behavioral program) | No |
| Insurance navigation | Yes | No |
Henry Meds ships faster. Found's 5–7 business day shipping is among the slower options in telehealth — patients who need medication quickly should factor that in. Neither platform includes metabolic lab testing as a standard feature.
Who is Found best for?
- Patients who want behavioral coaching alongside medication — The program model adds measurable value for patients who will engage with it, particularly those concerned about weight regain after stopping GLP-1s
- Patients who need insurance navigation — Found handles prior authorization for brand-name GLP-1s, including Wegovy and Zepbound
- Medicare patients — Found's Medicare Bridge Program provides a clear path to GLP-1 access at approximately $50/month copay
- Patients who want video consultations with obesity medicine specialists, not just async messaging
- Those pursuing brand-name medications who want clinical support alongside the prescription
Who is Henry Meds best for?
- Patients who want compounded tirzepatide at the lowest transparent cash price — $349/month is the most accessible tirzepatide entry point between these two providers; Found's Zepbound is more expensive all-in
- Budget-focused cash-pay patients who understand the compounded vs. brand distinction and do not need coaching, labs, or insurance navigation
- Self-directed patients who are comfortable managing their own dosing and side effects through async messaging
- Long-term semaglutide patients seeking the loyalty discount — $129/month after six months is cheaper than anything Found offers at the semaglutide tier
How We Evaluated
We compared Found and Henry Meds across five dimensions: all-in monthly pricing at each medication tier, formulary breadth and regulatory status, clinical support model (coaching, consultation format, labs), insurance navigation, and company profile. Pricing was verified against each provider's public website and verified checkout data in March–April 2026. Found's program fee is not publicly itemized — total cost should be verified at enrollment. Telehealth Ally has no commercial relationship with either provider — editorial assessments are independent.
Summary table
| Factor | Found | Henry Meds |
|---|---|---|
| Compounded semaglutide | ❌ | ✅ $149/mo |
| Compounded tirzepatide | ❌ | ✅ $349/mo |
| Orforglipron (pending) | ✅ $149/mo + fee | ❌ |
| Brand Zepbound | ✅ $299/mo + fee | ❌ |
| Behavioral coaching | ✅ | ❌ |
| Video consultations | ✅ | ❌ |
| Insurance navigation | ✅ | ❌ |
| Loyalty discount | ❌ | ✅ $129/mo at 6+ months |
| Shipping | 5–7 days | 3–5 days |
| Our rating | 4.2/5 | 3.5/5 |
Frequently Asked Questions
Which is cheaper: Found or Henry Meds? Henry Meds is cheaper for medication-only access. Compounded semaglutide is $149/month at Henry Meds with no added fee; Found charges $149/month for orforglipron plus an undisclosed program fee, making the all-in cost higher. For tirzepatide: Henry Meds' compounded version is $349/month flat. Found's Zepbound access is $299/month plus the program fee — higher total. Henry Meds is the right choice if you want the lowest monthly cost. Found is the right choice if you want coaching and insurance support, and are willing to pay for it.
Does Found include coaching that Henry Meds does not? Yes. Found includes behavioral coaching, community support, and structured curriculum as part of the program. Video consultations with obesity medicine specialists are available. Henry Meds is an async-only prescribing platform — there is no coaching or lifestyle program. If behavioral support matters to your treatment plan, it is only available through Found between these two providers.
Can Found help me get Wegovy covered by insurance? Yes. Found handles prior authorization for injectable GLP-1 medications including Wegovy and Zepbound, and assists Medicare patients through their Medicare Bridge Program. Henry Meds is cash-pay only and does not offer any insurance navigation. Patients with insurance coverage for GLP-1s should use Found (or Calibrate or FORM Health) rather than Henry Meds.
Does Henry Meds offer tirzepatide? Yes. Henry Meds offers compounded tirzepatide at $349/month from 503B-registered pharmacies. This is the cheaper tirzepatide option between these two providers — Found's brand Zepbound costs $299/month plus their program fee. Compounded tirzepatide is not FDA-approved as a finished drug product; it is produced by FDA-inspected 503B outsourcing facilities operating under cGMP standards.
Which is better for long-term results? Research is ongoing on what predicts long-term weight maintenance after GLP-1 treatment. The STEP 1 extension trial data showed approximately 67% weight regain in the year after semaglutide discontinuation — the biggest predictor of long-term outcome is what happens when medication stops. Found's behavioral coaching model is designed to build habits that reduce that regain risk. Henry Meds provides medication access but no behavioral framework. For patients who plan to eventually stop GLP-1 medication, Found's program structure offers more long-term support than Henry Meds' prescription-only approach.
Related Resources
- Found Weight Loss Review — Full Found program analysis
- Henry Meds Review — Full Henry Meds analysis
- Found vs Calibrate Comparison — Found vs a more comprehensive clinical program
- Mochi Health vs Found — How Found compares to Mochi's specialist model
- Henry Meds vs Hims for GLP-1 — Henry Meds head-to-head with another competitor
Related Guides
Best GLP-1 Options After Foundayo Approval: Oral vs Injectable 2026
Read guide →Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of April 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in April 2026. Here's what patients need to know and what to do.
Read guide →